A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...
Type 1 diabetes has shifted from a condition once associated with early mortality to a chronic disease owing to the development of intensive insulin therapy, continuous glucose monitoring, and hybrid ...
One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand ...
February 25, 2026 marks one year since KJ, an infant born with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, became the world's first person to receive a personalized CRISPR-based gene ...
Researchers at UChicago have developed a nanoparticle system that can effectively deliver mRNA to insulin-producing cells, protecting them from the body’s autoimmune response ...
One of the most promising is its cardiovascular disease therapy candidate CTX310, a single-treatment gene therapy that has ...
The cardiology landscape is rapidly evolving. Novel risk factors and new tools are reshaping CV risk assessment and ...
8d
CRISPR Therapeutics AG (CRSP) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript
Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 10:45 AM ESTCompany ParticipantsSamarth Kulkarni - CEO ...
Indian American researcher developing a novel type of living T cell-based therapy to tackle obesity-induced diabetes ...
Today, the American Diabetes Association(R) (ADA) announced the awardees of the 2026 Pathway to Stop Diabetes(R) (Pathway) Award grants. The seven new awards, totaling $11.3 million in strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results